Navigation Links
Shire Delivers Strong 2012 Results and Reiterates Confidence in 2013
Date:2/14/2013

31, 2012 2011 2012 2012 % % of total $M $M change revenue Net product sales: Specialty Pharmaceuticals Behavioral Health VYVANSE 1,029.8 805.0 28% 22% ADDERALL XR 429.0 532.8 -19% 9% INTUNIV 287.8 223.0 29% 6% EQUASYM(R) 29.2 19.9 47% 1% 1,775.8 1,580.7 12% 38% Gastro Intestinal LIALDA/MEZAVANT 399.9 372.1 7% 9% PENTASA 265.8 251.4 6% 6% RESOLOR 11.8 6.1 93% <1% 677.5 629.6 8% 15% General products FOSRENOL 172.0 166.9 3% 4% XAGRID(R) 97.2 90.6 7% 2% 269.2 257.5 5% 6% Other product sales 112.4 147.8 -24% 2% Total SP product sales 2,834.9 2,615.6 8% 61% Human Genetic Therapies ELAPRASE 497.6 464.9 7% 11% REPLAGAL 497.5 475.2 5% 11% VPRIV 306.6 256.2 20% 6% FIRAZYR 116.3 33.0 252% 2% Total HGT product sales 1,418.0 1,229.3 15% 30% Regenerative Medicine DERMAGRAFT 153.8 105.3 46% 3% Total RM product sales 153.8 105.3 46% 3% Total product sales 4,406.7 3,950.2 12% 94% Royalties: 3TC and ZEFFIX 91.6 82.7 11% 2% ADDERALL XR 70.3 107.1 -34% 2% FOSRENOL 53.3 46.5 15% 1% Other 26.4 47.2 -44% <1% Total royalties 241.6 283.5 -15% 5% Other revenues 32.9 29.7 11% 1% Total revenues 4,681.2 4,263.4 10% 100%

Unaudited US GAAP results for the three months to December 31, 2012

Selected Notes to the Financial Statements

(2)  Analysis of revenues

3 months to December 31, 2012 2011 2012 2012 % % of total $M $M change revenue Net product sales: Specialty Pharmaceuticals Behavioral Health VYVANSE 256.5 217.1 18% 21% ADDERALL XR 81.5 124.8 -35% 7% INTUNIV 81.2 65.4 24% 7% EQUASYM 7.9 4.3 84% 1% 427.1 411.6 4% 36% Gastro Intestinal LIALDA/MEZAVANT 111.4 96.1 16% 9% PENTASA 69.1 65.2 6% 6% RESOLOR 3.5 2.1 67% <1% 184.0 163.4 13% 15% General products FOSRENOL 45.2 39.9 13% 4% XAGRID 26.5 21.4 24% 2% 71.7 61.3 17% 6% Other product sales 26.5 30.5 -13% 2% Total SP product sales 709.3 666.8 6% 59% Human Genetic Therapies ELAPRASE 139.3 124.0 12% 12% REPLAGAL 118.2 120.9 -2% 10% VPRIV 77.3 69.3 12% 6% FIRAZYR 34.6 14.9 132% 3% Tot
'/>"/>

SOURCE Shire plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine technology :

1. Shire Regenerative Medicine and HealTogether Partner with Celebrity Chef Charles Mattocks to Raise Awareness of Diabetes and its Complications
2. NYSE Hot Stocks Earnings Forecast: Wells Fargo, Eli Lilly, Berkshire Hathaway, Coca-Cola, Valero Energy, and Altria Group
3. Shire Leads New Initiative to Reveal Challenges Facing Rare Disease Community
4. Dr Steven Gillis to Join Shire Board of Directors
5. Shire Second Quarter Product Sales Up 16%
6. Shire Announces that the US Food and Drug Administration has Responded to its Citizen Petition for Adderall XR and has Approved One Abbreviated New Drug Application for Generic Adderall XR
7. Shire to Present Scientific Data Across Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting May 5-9
8. Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth
9. Maroon 5 Lead Singer Adam Levine and Shire Announce "The Own It Project," Encouraging Adults with Attention-Deficit/Hyperactivity Disorder to Tell Their Stories Through a National Contest
10. Study Delivers Investment Benchmarks across Key New Product Launch Activities in Pharmaceutical Sector
11. SIS Delivers Advanced Interoperability With Siemens Soarian Clinicals To Improve Efficiency, Communication
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Dec. 24, 2014 /CNW/ -   ... recalled after Health Canada tests confirmed it contains two ... (beta-methylphenethylamine and phenylpropylmethylamine). The distributor, Empire Health Distribution of ... product from retail stores across Canada ... including for weight loss and increased energy. ...
(Date:12/24/2014)... Tianyin Pharmaceutical Inc. (NYSE Amex: TPI ... patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded ... preliminary financial results for the first quarter of ... Ended September 30, 2014 Financial Highlights: , ... in 1Q14 with gross margins improved to 52% ...
(Date:12/24/2014)... 2014  Conkwest, Inc., the Natural Killer Cell ... Killer (NK) cell-line platform, Neukoplast® (NK-92™) as an ... , NantWorks founder, physician scientist and biotechnology entrepreneur, ... approximately $48 million of the Company,s Class A ... will be named Co-Chairman of the Conkwest Board ...
Breaking Medicine Technology:"Jetfuel Superburn" recalled after Health Canada tests find undeclared drug ingredients 2TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 2TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 3TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 5TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 6TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 7TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 8TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 9TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 10TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 11TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 12Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 2Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 3Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 4Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 5
(Date:12/25/2014)... December 26, 2014 The ... combines beauty, strength and durability. Today, the business ... which is valid until Jan. 30, 2015. , ... of traditional hardwood. BambooFlooringChina.com is a well-known brand ... consumers worldwide to find a reliable bamboo flooring ...
(Date:12/25/2014)... months the trends for evening dresses shift and ... of the hottest styles in the next few months.” The ... 26 A-line sweetheart evening dresses, and announces the availability of ... trying our best to help a lady to show off ... prices, we provide discounted delivery costs to our customers worldwide. ...
(Date:12/25/2014)... December 25, 2014 Recently, BellasDress ... on all its wedding dresses. BellasDress has chosen their ... for gift choices for the holiday season. , ... pick suitable wedding gowns here at discount prices. The ... experience at its website. , “All our ...
(Date:12/25/2014)... Recently, LunaDress.co.uk has updated its blog to provide professional shopping tips ... the models at LunaDress.co.uk come with big discounts, up to 80 ... can turn out to be a most exciting memory and can ... bring surprise to a wedding. On the updated fashion blog, ladies ... for a big day . , Going out with friends to ...
(Date:12/25/2014)... 2014 (HealthDay News) -- Among early stage breast cancer ... half of one percent will eventually develop leukemia as ... The finding comes from a review of more ... 2007, and it suggests that the risk for developing ... had previously thought. "The frequency of bone marrow ...
Breaking Medicine News(10 mins):Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3
... , LISLE, IL , Feb. 8 /PRNewswire-FirstCall/ - SXC ... a conference call on Thursday, March 4, 2010 at ... and year end financial results. Mark Thierer , President and CEO, ... the call. , All interested parties can join the call by dialing ...
... A team of researchers, led by Pier Paolo Pandolfi, ... a new type of cellular senescence (i.e., irreversible arrest ... it to suppress prostate tumor development and growth in ... that inactivation of the protein Pten leads to a ...
... with Alzheimer,s disease (latrepirdine) appears well tolerated and may ... Huntington,s disease, according to a report in the February ... the JAMA/Archives journals. "Huntington,s disease is a hereditary ... leads to death within 20 years of disease onset," ...
... trouble organizing thoughts, but not memory loss , MONDAY, ... predict dementia in older adults with impaired executive function ... those with memory problems, a new study has found. ... 83, who were followed-up for five years. During that ...
... ... industry professionals, academics, and students to discuss the key issues facing the health care ... groundbreaking ways in which companies and individuals across every sector of health care are ... ...
... , PHILADELPHIA , Feb. 8 Independence Blue ... to the newly created role of senior vice president of ... and chief marketing executive, Linda M. Taylor . , ... that help health care consumers better manage their care and will ...
Cached Medicine News:Health News:SXC Health Solutions to Host Fiscal 2009 Fourth Quarter and Year End Results Conference Call 2Health News:Medication appears well-tolerated, beneficial in Huntington's disease patients 2Health News:High Blood Pressure May Predict Dementia in Some Seniors 2Health News:2010 Wharton Health Care Business Conference - Feb. 25-26, Philadelphia, PA 2Health News:2010 Wharton Health Care Business Conference - Feb. 25-26, Philadelphia, PA 3Health News:Independence Blue Cross Names John Janney to Newly Created Position: Senior Vice President Marketing Services 2Health News:Independence Blue Cross Names John Janney to Newly Created Position: Senior Vice President Marketing Services 3
Revised Drug calibrator that replaces existing Drug calibrator - this product contains Lithium in addition to Digoxin, Phenobarbital, OPhenytoin, & Theophulline....
The Emit 2000 Digoxin Calibrators are intended for use with the Emit 2000 Digoxin Assay....
Liquichek Rheumatoid Factor Control is a liquid trilevel control designed to monitor rheumatoid factor testing procedures, including nephelometric and latex agglutination methods....
... The BD Macro-Vue RPR (Rapid Plasma ... Tear-drop Tests are nontreponemal testing procedures ... described in A Manual of Tests ... this manual are the most widely ...
Medicine Products: